The Medicines Company to Announce Fourth Quarter and Full Year 2011 Financial Results on Wednesday, February 22, 2012
Conference Call to Be Held at 8:30 a.m. Eastern Time
(firmenpresse) - PARSIPPANY, NJ -- (Marketwire) -- 02/03/12 -- The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, February 22nd at 8:30 a.m. Eastern Time to discuss fourth quarter and full year 2011 financial results, operational developments, and outlook for 2012.
The conference call will be available via phone and webcast. The dial in information is listed below:
Domestic Dial In: 866-510-0705
International Dial In: 617-597-5363
Passcode for both dial in numbers: 54805335
Replay is available from 10:30 a.m. Eastern Time following the conference call through March 7, 2012. To hear a replay of the call dial 888-286-8010 (domestic) and 617-801-6888 (international). Passcode for both dial in numbers is 95010339.
This call is being webcast and can be accessed at The Medicines Company website at .
The Medicines Company (NASDAQ: MDCO) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients. The Medicines Company's website is .
Contact:
Michael Mitchell
Investor Relations
The Medicines Company
973-290-6000
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.02.2012 - 15:15 Uhr
Sprache: Deutsch
News-ID 1079474
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
PARSIPPANY, NJ
Phone:
Kategorie:
Drugs
Anmerkungen:
Diese Pressemitteilung wurde bisher 134 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"The Medicines Company to Announce Fourth Quarter and Full Year 2011 Financial Results on Wednesday, February 22, 2012
"
steht unter der journalistisch-redaktionellen Verantwortung von
The Medicines Company (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
